Home / David L. Joffe, BSPharm, CDE, FACA (page 10)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

May 1, 2018

When I was doing Diabetes CME for clinicians and pharmacists I had a couple of slides that showed a patient hooked up to a machine as big as a small car. This device was able to control glucose levels way back in the 70’s. The question we used to ask …

Read More »

April 28, 2018

I was having dinner with a group of cycling couples recently We are all participating in the Bike Virginia 6-day riding event in late June and we were discussing travel plans. One of the participants is an optometrist and we got into a discussion about prescription sunglasses for the ride. …

Read More »

April 24, 2018

Last week we had some great Homerun Slides on Albuminuria. We generated a lot of interest in what is the best way to ward off Kidney Disease. So this week we have an exclusive interview with one of the most well known names in Kidney Disease, Dr. George Bakris. During …

Read More »

April 21, 2018

I have been a fan of Indigogo and Kickstarter for the last couple of years and have invested in some good products and some not-so-good products. I have a Twicycle (https://twicycle.com) and Ice Plate – The DIY At Home Ice Cream Roll Maker on its way. They also have a …

Read More »

April 17, 2018

The guideline for all diabetes patients is to get them on an ACE or an ARB when diagnosed, regardless of BP levels. This is so important that Medicare and Medicaid rate prescribers based on their patients’ adherence to these medications. The logic behind that rule has to do with the …

Read More »

April 14, 2018

A couple of days ago we sent out our latest therapy update on SGLT-2 Inhibitors. This class of drugs shows multiple ways to decrease A1c values with a small risk of hypoglycemia. This means that individual glucose levels often are not of concern. This is not true with our insulin-using …

Read More »

April 12, 2018

As I was reviewing this months SGLT-2 Therapy edition I was reminded of how much this class of drugs has opened up dialogues on patient care in multiple disease states. With the older diabetes medications we talked A1c, Fasting, or Postprandial; all related to diabetes and there was not much …

Read More »

April 10, 2018

When we talk to patients about prediabetes, one of the topics of discussion is likely to be about insulin resistance. However, what we are usually describing is glucose resistance. The lecture usually goes something like this: “If you eat too much sugar, then your cells get filled with the sugar …

Read More »

April 7, 2018

I have recently intensified my cycling training as I prepare for an 80 mile and 6000 foot climbing ride in Chattanooga next month. To get ready I have to switch from riding with our bike club 90% of the time to solo riding with a power meter and heart monitor …

Read More »

April 3, 2018

This year the ACC and AHA announced new Blood Pressure guidelines that have been shared by every medical newsletter and journal. The idea is to reduce heart failure and death by improving patient care. Not only were there new guidelines, there were also new definitions and descriptions as to what heart failure looks like. This week we have …

Read More »